PML::RARA and GATA2 proteins interact via DNA templates to induce aberrant self-renewal in mouse and human

Casey D S Katerndahl1, Olivia R S Rogers1, Ryan B Day1

  • 1Division of Oncology, Department of Internal Medicine, Section of Stem Cell Biology, Washington University School of Medicine, St. Louis, MO 63110.

Insights

The PML::RARA fusion protein initiates acute promyelocytic leukemia by activating GATA2 expression. GATA2 binding creates accessible chromatin, enabling PML::RARA to bind DNA and drive disease progression.

Area of Science:

  • Hematology
  • Molecular Biology
  • Cancer Biology

Background:

  • The precise mechanism by which the PML::RARA fusion protein drives acute promyelocytic leukemia (APL) remains incompletely understood.
  • Identifying the direct genomic targets and interacting partners of PML::RARA is crucial for elucidating APL pathogenesis.

Purpose of the Study:

  • To define the genomic binding landscape of the PML::RARA fusion protein in hematopoietic progenitor cells.
  • To investigate the role of chromatin accessibility and transcription factors, particularly GATA2, in PML::RARA-mediated leukemogenesis.
  • To elucidate the functional relationship between PML::RARA and GATA2 in initiating the APL transcriptional program.

Main Methods:

  • Chromatin immunoprecipitation sequencing (ChIP-seq) and CUT&RUN assays to map PML::RARA genomic binding sites.
  • ATAC-seq to assess chromatin accessibility in hematopoietic progenitor cells.
  • Proximity labeling and co-immunoprecipitation to identify PML::RARA interacting proteins.
  • Gene manipulation (overexpression and inactivation) to study the functional role of GATA2.

Main Results:

  • PML::RARA predominantly binds to pre-existing accessible chromatin regions in wild-type cells.
  • GATA binding motifs and the pioneering factor GATA2 are significantly enriched near PML::RARA binding sites.
  • PML::RARA interacts with approximately 250 proteins, including GATA2, with some interactions stabilized by DNA binding.
  • GATA2 overexpression recapitulates key epigenetic and transcriptional changes induced by PML::RARA.
  • Inactivation of GATA2 prior to PML::RARA expression blocks leukemogenesis and self-renewal induction.

Conclusions:

  • PML::RARA initiates its oncogenic program by leveraging pre-existing accessible chromatin regions, often associated with GATA motifs.
  • GATA2 acts as a critical mediator, potentially by creating accessible chromatin and interacting with PML::RARA.
  • PML::RARA positively regulates GATA2 expression in a feed-forward loop, which is essential for establishing the leukemic transcriptional program and driving self-renewal.